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450 « 1996 Annual Meeting Abstracts MEDICAL DECISION MAKING
CRITICIZING CURRENT SURGICAL POLICIES IN TESTICULAR CANCER USING THE 
JUDGEMENT OF THE CLINICIANS THEMSELVES
FW Stftvarhara. PhB Marshall. HJ Kaizar. JDF Habbema. Department of Public Health, Erasmus 
University, Rotterdam and University HospilaF, Leiden, The Netherlands.
Metastatic testicular cancer can be cured in the majority of patients by chemotherapy. Alter 
chemotherapy, residual masses of Ihe initial metastases may remain, which may effectively be 
removed by a surgical resection. The selection of patients varies widely lor this procedure, with 
resection rates between 25% and 80%. This variation is largely explained by differences in 
management ot patients with small residual masses (0.20mm). In this analysis we therefore 
aimed to evaluate the potential benefit or harm caused by resection of small masses.
A decision analysis model was constructed for the strategies ’resection’ and 'follow-up'. The 
outcome considered was the 5-year survival rale. With each strategy, one of three histologies 
may be present in the residual mass. First, fully benign tissue (necrosis) has the same prognosis, 
whether resected or not. Second, mature teratoma is potentially malignant and may grow, causing 
additional risks if not resected. Third, the presence of cancer cells indicates that the patient was 
not completely cured, and that additions chemotherapy is indicated. Prognostic estimates for 
follow-up of mature teratoma or cancer are not observable, since resection is the only reliable way 
to determine the histological diagnosis. We therefore elicited these estimates from 7 expert 
clinicians, The clinicians came Irom centers representing the whole spectrum of currently used 
selection policies. The prognostic estimates were averaged* and a plausible range was
constructed for each estimate.
When using average estimates, a 4.4% higher 5-year survival rate was expected with 
resection of masses 11-20mm In size. For very small masses (0-10mm), a 2.3% higher 5-year 
survival rate was expected. The benefit of resection was rather robust when the estimates were 
varied over their plausible ranges. The minimum benefits according to the individual clinicians' 
estimates were 2.2% and O.B% respectively.
In conclusion, the clinicians' own judgements indicate a substantial benefit of resection, even 
in very small residual masses, Current surgical policies for residual masses therefore need to be 
reconsidered.
"STATE" VERSUS “PROCESS* DESCRIPTIVE FORMATS: EFFECTS O N  PREFERENCES.
PFM Krabbe. IDF Hnbhema. IJC  Leven dag. CA Mccuwis. PIM Schmitt. Center for Clinical Decision Sciences, 
Department o f Public Health, Faculty of Medici tic, Erasmus University Rotterdam, and Dr. Daniel den Hoed 
Cancer Center, The Netherlands,
Purpose. Utilities incorporated in computations for quality-adjusted life years (QALYs} arc conventionally elicited 
by presenting concise descriptive formats to respondents on the stable end-state after a particular treatment. We 
compared such a “state" description based approach with a “process” procedure which contains detailed infor­
mation o f  the entire treatment regime.
M ethods, Laryngeal cancer, the object o f  our study, is treated by radiation therapy (RTJ or by surgical removal 
o f the larynx including the vocal cords (S), Two different descriptive formats for both RT and S were used. “State" 
is a brief description with relevant information about the stable end-state after RT or S. T he  "Process" descrip­
ción included detailed information about: tumor recurrence rates, 5-year survival rates, grade o f  mutilation, physi­
cal impairment and side-effccis.
The time-tradeofFmethod was used to elicit utilities for the two treatments for both descriptive formats. Twa 
groups o f respondents were selected to participate: former laryngeal cancer patients (n=24) and a control group 
(n*=24). O ne half o f  each group valued the State or the Process descriptions. Utilities elicited by the State descrip­
tions were incorporated, which is the conventionally practice, into a decision-tree for the computation o f QALYs. 
Process based utilities were used directly.
Results. The two descriptive formats gave different results. Former patients and controls exhibited largely similar 
patterns. Utilities elicited by Process were on average almost similar for RT and S. For State descriptions, aver­
age utilities were higher for RT than for S. An interesting finding among the former patients was that in g en ­
eral those who preferred RT rcsp. S were also treated by RT resp, S in the  past.
Conclusions. Different utilities were elicited for State and Process. Several reasons may be responsible for this. 
In particular the type and am ount o f  informarían may affect individual assessments, T h e  com m on practice oF 
the formalized QALY methodology ro incorporate utilities elicited by State-like descriptions may be a too restric­
tive pioceduTc for the respondents. O n the other hand, performing evaluations based on Process-like descriptions 
demands without any doubt a considerable cognitive task o f participants. Research into the causes o f the differ­
ences in  results between the "State“ and the "Process" approach is required.
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SEQ U EN C E EFFECTS IN TRADEOFFS: ARE G O O D  YEARS AFTER BAD YEARS BETTER TH A N  
T H E  REVERSE?
PFM  Krabbe. MLEssink-Bor. G l Bansel. Department o f  Public Health, Faculty o f  Medicine, Erasmus Univer­
sity Rotterdam, and Department o f  Clinical Epidemiology and Biostatistics, Acadcmtc Medical Centre Amsterdam, 
T he  Netherlands,
Purpose. We studied whether a different sequence o f health states in a health profile yields different valuations. 
M ethods. The empirical task was part of a large standardized experiment involving 104 students. Thirteen 
health states were valued by two different modes of a modification of th e T T O  method.
The standard mode for T T O  determined indifference between 10 years in suboptimal stare A versus X  years 
in "perfect health” followed by 10-Xyears in the "worst imaginable health state” (the risk for rhe respondents was 
to assess X). T he experimental, reverse mode for T T O  offered the same tradeoff task, hut here Y years in the 
V o ts t  imaginable health state” were followed by 10-Y years lit "perfect health", If  sequence effects were absent, 
X should equal 10-Y. “Worst imaginable health state” rather than “dead" was chosen as a reference outcome 
v?hich enable us to  construct health profiles and to avoid negative T T O  values for health states worse chan death. 
Result«. A small b u t distinct overall effect o f  sequence was detected for the bad health states. Apparently, respon­
dents prefer starting with the bad years ending up healthy rather than the reverse, despite a dear instruction that 
health would return to normal alter 10 years.
Detailed analysis at the individual level showed that a proportion of the respondents could be classified as 
sensitive for the sequence o f the events in time, either preferring best years 
first, or rhe reverse; “happy end" respondents,
Conclusions. Wc found a sequence effect in our study: X was valued less than 
10-Y for the bad health states. The sequence effect in our study contradicts 
conventional time preference (discounting), which in particular affects re­
m ote years in full health. These results suggests that a lifetime health profile 
may not simply be regarded as a chain of separately valued QALY periods.
Furthermore, the results are conflicting with the constant proportional tradeoff 
assumption o f  the T T O  method,
ARE METHODS FOR CALCULATING QALYs IN COST-EFFECTIVENESS ANALYSES 
IMPROVING?
FJ Neumann and DE Zinner. Harvard School of public Health, Boston, Massachusetts, and Massachusetts 
Institute of Technology, Cambridge, Massachusetts.
Objectives. The objectives of 1his paper are: 1) to investigate variations among cost-cffectiveness analyses 
in the published literature in their methods used to calculate QALYs; And 2) to examine whether these 
methods have been improving over time.
D ata and Methods. Using a MEDHNB database search, wc identified 86 original cost-effectiveness 
analyses, published between 1975 and 1995, which used QALYs as the measure of effectiveness. For each 
study, we recorded: the health slate classification system employed: the measurement technique used as the 
basis of valuing health states; and whose preferences were used in the calculation. Two readers evaluated 
each study independently, then met to reach consensus. Wc also examined whether methods adhered (o 
"good practices” as defined by the U.S. Panel on Cost-EHectiveness in Health and Medicine, and whether 
methods have been improving over lime.
Results. 20%  of studies used a pre-existing health state classification scale (e.g., Health Utilities Index). 
Most studies (59%) assigned quality-of-life weights to health states particular to the condition under 
investigation (e.g., minor toxicity with chemotherapy); 13% of studies employed a single “general disability” 
state. The source of the preferences were mostly those of the study authors themselves (45%), followed by 
community (21%) clinician (15%), and patient (13%) preferences, respectively, In 8% o f  studies, the source 
was not explicitly stated. A variety of measurement techniques for valuing health states "were used, including 
author’s judgment (45%), lime tradeoff (17%), category or rating scale (17%), and standard gamble (4%). 
In 15% of oases, the technique could not be determined. Few studies adhered to good practices ns defined 
by the Panel, and there was little evidence that methods have been improving over time.
Conclusions. The results illustrate extensive variation in the manner in which QALYs have been calculated, 
and suggest the need for more scientific rigor and consistency with respect to the methods used,
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MEASURING STAKEHOLDER PREFERENCES FOR SCHIZOPHRENIA OUTCOMES 
Martha Shumwav. University of California, San Francisco, California.
Understanding stakeholder preferences is essential for identification of effective 
treatments for schizophrenia, a severe and chronic psychiatric disorder with multiple, 
conflicting outcomes. However, measuring preferences for schizophrenia outcomes 
poses special challenges. First, several stakeholder groups are involved In 
schizophrenia treatment, including patients, patient's families, clinicians, and members 
of the general public,’ Second, p3tients*>whose preferences are most central-often 
have psychiatric symptoms which limit their ability to express their preferences.
Three studies examined the suitability of 4 preference assessment methods 
I Category Rating, Time Trade-off, Paired Comparison and Direct Importance Rating) for 
evaluating schizophrenia outcomes. In the first study, 21 clinicians evaluated all 4 
methods in focus groups. Ail methods were more difficult to use than anticipated. 
Time Trade-off was significantly more difficult than other methods, The methods also 
yielded different rankings of 7 key outcomes, The second study examined the effects 
of 2 presentation formats and 2 time frames on clinician's Time Trade-off ratings of 
schizophrenic health states, Format and time frame did affect ratings, but did not ~ 
affect task comprehension or ease of use, In the third study, 20 persons with 
schizophrenia evaluated the Category Rating, Paired Comparison and Direct Importance 
Rating methods in individual interviews. They favored the Direct Importance method 
which took the least time, however the Category Rating and Paired Comparison 
methods also appeared comprehensible and acceptable.
These studies suggest that standard preference assessment methods are suitable 
for measuring stakeholder preferences for schizophrenia outcomes. However, both 
clinicians and patients found the methods challenging and felt they would have 
difficulty evaluating a large number of health states. The Tfme Trade-off method 
appears less suitable than other methods, possibly due to the chronic, but highly 
variable, course of schizophrenic illness.
THE MCMASTER HEALTH UTILITY INDEX (II) AND THE EUR0Q0L-5D ASSESSED IN PATIENTS WITH 
PERIPHERAL ARTERIAL DISEASE IN THE UNITED STATES AND THE NETHERLANDS.
JL Bosch. £EE van W ilck. PL Baum. MC Donaldson, JJAM van.den D u n m  MOM Hutllnk, University of 
Groningen and University Hospital Groningen, the Netherlands, Harvard School of Public Health and Harvard 
Medical School, Boston, Massachusetts.
purpose: To assess the relationship between the McMaster HUI (II) and the EQ-5D In the USA and the 
Netherlands, and to compare health profiles of patients with claudication {I.e. mildest stage of peripheral arterial 
disease) and a major amputation (most severe stage) based on responses to the McMaster HUi (II) and EQ-5D. 
Methods: TTie McMaster HUI (II) and EQ-5D were completed by 112 patients with peripheral arterial disease 
(Dutch: n»73, American: n=39; claudication: n=38, major amputation: n=H critical ischemia: n=6, minor amputation 
n=13j after revascularization: n=41). The relationship between the two Indices was assessed with a correlation 
coefficient (r}. The modes of the responses to the various dimensions of the health profiles were compared.
Results; Altthough the mean McMaster HUI (II) and EQ-5D values were significantly different (0.70 (SD 0,22) 
versus 0,54 (SD 0.26) respectively), the values correlated moderately well (r10.41). Since the McMaster HUI (II) 
formula is based on SO. utilities and the EQ>5D index on RS values, we transformed the EQ-50 with Torrance’s 
transformation. This improved the relationship between the two Indices onfy slightly (f * 0,44). No differences In 
outcomes or the correlation coefficient between the two countries were demonstrated. The mean McMaster HUI (II) 
and mean EQ-5D were significantly different in the claudication group, 0.78 (SD 0,15) versus 0.51 (SD 0.21) 
respectively, and in ihe amputation group 0,61 (SD 0.19) versus 0.43 (SD 0,24) respectively (p < 0.05). The mean 
values ol the McMaster HUI (II) differed significantly for claudication compared with amputation (p < 0.05), whereas 
this was not the case lor Ihe mean EQ-5D values, In addition, the health profiles for claudication and amputation 
based on the McMaster HUI (II) responses demonstrated differences in the dimensions mobility and pain, whereas 
the EQ-5D values yielded equivalent health profiles for these two health states,
Conclusion: Although the McMaster HUI (II) was developed In North America and the EQ-5D In Europe this 
affected neither the outcomes nor the relationship between the Indices across countries, The EQ-5D yielded 
lower values than the McMaster HUI (II), which was not explained by transforming the RS-based EQ-5D index to 
aSG  utility. Finally, the McMaster HUI (II) was more discriminative between different stages of peripheral 
arterial disease than the EQ-50.
